RESI Boston Panel Announcement: Early Stage Therapeutics Investors

11 Aug

By Lucy Parkinson, Director of Research, LSN

Boston is often called the center of the global biotechnology industry, and it’s therefore no surprise that investors are flocking to RESI Boston to meet with early stage drug development entrepreneurs. LSN has gathered a panel of 5 top investors in therapeutics to share their tips and insights on the assessment of novel therapeutic technologies.

These five panelists will be sharing their expertise with RESI’s audience:

The panel will cover the challenges of raising capital for early stage drug development.  It’s a high-risk, high-reward investment sector, and these five investors have a wealth of experience in searching for the strongest early stage opportunities.  Representing diverse groups, from foundations to VC to pharma, these investors will explain how you can position your company to work with them.  If you’re interested in catching this panel live, you can sign up for RESI Boston now.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: